Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly R Keir

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|February 24, 2022
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapyHolly R Keir, James D Chalmers
Chest|November 7, 2022
Rebuttal From Dr Keir and Prof ChalmersHolly R Keir, James D Chalmers
The European Respiratory Journal|December 17, 2021
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasisJames D Chalmers, Holly R Keir
The European Respiratory Journal|September 22, 2017
10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPDJames D Chalmers, Holly R Keir
Respirology (Carlton, Vic.)|April 13, 2022
Bronchiectasis enters the inflammation eraHolly R Keir, James D Chalmers
The European Respiratory Journal|October 15, 2021
IL-6 trans-signalling: how <i>Haemophilus</i> surfs the NET to amplify inflammation in COPDHolly R Keir, James D Chalmers
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Pathophysiology of BronchiectasisHolly R Keir, James D Chalmers
Chest|November 7, 2022
COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? NoHolly R Keir, James D Chalmers
Biomedicines|October 23, 2021
Inhaled Corticosteroids and the Lung Microbiome in COPDHolly R Keir, Marco Contoli, James D Chalmers
Respirology (Carlton, Vic.)|June 29, 2017
The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Simon Finch, Holly R Keir, Alison J Dicker, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
European Respiratory Review : an Official Journal of the European Respiratory Society|February 24, 2022
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapyHolly R Keir, James D Chalmers
Chest|November 7, 2022
Rebuttal From Dr Keir and Prof ChalmersHolly R Keir, James D Chalmers
The European Respiratory Journal|December 17, 2021
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasisJames D Chalmers, Holly R Keir
The European Respiratory Journal|September 22, 2017
10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPDJames D Chalmers, Holly R Keir
Respirology (Carlton, Vic.)|April 13, 2022
Bronchiectasis enters the inflammation eraHolly R Keir, James D Chalmers
The European Respiratory Journal|October 15, 2021
IL-6 trans-signalling: how <i>Haemophilus</i> surfs the NET to amplify inflammation in COPDHolly R Keir, James D Chalmers
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Pathophysiology of BronchiectasisHolly R Keir, James D Chalmers
Chest|November 7, 2022
COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? NoHolly R Keir, James D Chalmers
Biomedicines|October 23, 2021
Inhaled Corticosteroids and the Lung Microbiome in COPDHolly R Keir, Marco Contoli, James D Chalmers
Respirology (Carlton, Vic.)|June 29, 2017
The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Simon Finch, Holly R Keir, Alison J Dicker, et al.
Pageof 6